Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review
ConclusionsModel-based cost-effectiveness analyses of systemic mCRC treatments have adopted varied modelling methods and structures, resulting in substantially different outcomes. As models generally focus on first-line treatment without consideration of downstream treatments, there is a profound source of structural uncertainty implying that the cost-effectiveness of treatments across the mCRC pathway remains uncertain.
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Databases & Libraries | Eloxatin | Health Management | Study | UK Health